Removal of a gadolinium based contrast agent by a novel sorbent hemoperfusion in a chronic kidney disease (CKD) rodent model

Gadolinium based contrast agents (GBCAs) have been linked to toxicity in patients, regardless of having impaired or normal renal function. Currently, no therapy is considered highly effective for removing gadolinium (Gd) from the body. We propose a new strategy to reduce blood Gd content that facili...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Sci Rep
Hlavní autoři: Ngamcherdtrakul, Worapol, Morry, Jingga, Sangvanich, Thanapon, Reda, Moataz, Bejan, Daniel S., Fryxell, Glen E., Yantasee, Wassana
Médium: Artigo
Jazyk:Inglês
Vydáno: Nature Publishing Group UK 2019
Témata:
Article
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC6345740/
https://ncbi.nlm.nih.gov/pubmed/30679698
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/s41598-018-37348-2
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky